Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R
Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Diabet Med. 1999 Jul;16(7):573-8. doi: 10.1046/j.1464-5491.1999.00124.x.
To evaluate the outcome of two specific changes in the policy of managing pregnancy in Type 1 diabetes over a 5-year period. The need for change had been identified following an audit in the previous 5-year period: firstly, the need for intensive effort to improve the uptake of pre-pregnancy counselling; secondly, a modest relaxation of the targets for blood glucose control during labour to minimize the risk of maternal hypoglycaemia.
Data were collated from maternal and neonatal case notes from all women with Type 1 diabetes mellitus managed by Newcastle obstetric services between August 1989 and July 1994 (n = 80), comparing data with 40 such women looked after between November 1985 and July 1989.
The age of the women, blood glucose control during pregnancy, gestation at delivery, and birth weight were similar in the 5-year period under study to those previously reported for the first study period. Mean blood glucose in labour for Period 2 was 5.5 +/- 0.6 mmol/l, exactly 1.0 mmol/l higher than the mean blood glucose achieved in labour for Period 1. As a consequence, only 22.5% women (18/80) experienced one or more episodes of blood glucose less than 3.0 mmol/l compared with 40.0% women in Period 1 (16/40) (P < 0.01). There was no effect of maternal blood glucose on neonatal blood glucose provided the former was within the range 4-8 mmol/l during labour. However, if maternal blood glucose was over 10 mmol/l, the infant's blood glucose was always low (1.3 +/- 0.8 vs. 2.5 +/- 1.5 P < 0.02). Macrosomia (over the 90th percentile for gestational age) was observed in 43.1% of infants in Period 1, and the mean birth weight was not different from Period 1. In the initial 5-year period 27.5% (11/40) women received specific pre-pregnancy care for their diabetes, compared with 21.3% (17/80) in Period 2 despite the intensive programme of education. There were six cases of congenital abnormality and two antepartum deaths (10% adverse outcome).
The target range for blood glucose control in labour of 4-7 mmol/l minimizes maternal hypoglycaemia in labour and the data indicate that an upper limit of 8 mmol/l would not increase the risk of neonatal hypoglycaemia. Fresh thought is required about the matter of preventing congenital abnormalities by achieving better pre-pregnancy and peri-conception blood glucose control.
评估1型糖尿病妊娠管理政策中两项特定改变在5年期间的效果。在前一个5年期间的一次审计后确定了变革的必要性:第一,需要加大力度提高孕前咨询的接受率;第二,适度放宽分娩期间血糖控制目标,以尽量降低母体低血糖风险。
整理了1989年8月至1994年7月由纽卡斯尔产科服务机构管理的所有1型糖尿病女性的母婴病例记录数据(n = 80),并将这些数据与1985年11月至1989年7月期间照料的40名此类女性的数据进行比较。
在研究的5年期间,这些女性的年龄、孕期血糖控制、分娩孕周和出生体重与先前第一个研究期间报告的情况相似。第二阶段分娩时的平均血糖为5.5±0.6毫摩尔/升,比第一阶段分娩时的平均血糖恰好高1.0毫摩尔/升。因此,只有22.5%的女性(18/80)经历过一次或多次血糖低于3.0毫摩尔/升的情况,而第一阶段为40.0%的女性(16/40)(P < 0.01)。如果分娩期间母体血糖在4 - 8毫摩尔/升范围内,母体血糖对新生儿血糖没有影响。然而,如果母体血糖超过10毫摩尔/升,婴儿的血糖总是偏低(1.3±0.8对2.5±1.5,P < 0.02)。第一阶段43.1%的婴儿出现巨大儿(超过胎龄的第90百分位数),且平均出生体重与第一阶段无差异。在最初的5年期间,27.5%(11/40)的女性接受了针对其糖尿病的特定孕前护理,尽管有强化教育计划,但在第二阶段这一比例为21.3%(17/80)。有6例先天性异常和2例产前死亡(不良结局发生率为10%)。
分娩时血糖控制的目标范围为4 - 7毫摩尔/升可将分娩时母体低血糖风险降至最低,数据表明上限为8毫摩尔/升不会增加新生儿低血糖风险。需要重新思考通过在孕前和受孕期间更好地控制血糖来预防先天性异常的问题。